Helen Sabzevari is CEO & President at PRECIGEN, INC. (PGEN). They have made 12 open-market trades across 2 companies since 2018, most recently 2026-08-23.
CIK 0001724195
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $40K since 2023, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PGEN | 3,779,521 | $24.1M |
| XON | 104,734 | $487K |
| Total | $24.6M |
Shares reported on the most recent Form 4, priced at the 2026-08-25 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PGEN | SELL · 10b5-1 | 2026-06-29 | 2026-07-01 | $5.89 | $2.0M | -4.1% | +17.6% | +51.2% |
| PGEN | SELL | 2026-05-28 | 2026-06-01 | $4.36 | $520K | +10.5% | +28.6% | +69.2% |
| PGEN | SELL · 10b5-1 | 2023-08-25 | 2023-08-25 | $1.53 | $236K | -6.9% | -22.5% | -32.9% |
| PGEN | SELL · 10b5-1 | 2023-08-18 | 2023-08-18 | $1.66 | $185K | +14.2% | -11.1% | -29.0% |
| PGEN | SELL · 10b5-1 | 2023-08-11 | 2023-08-11 | $1.44 | $119K | +9.8% | +3.9% | -17.6% |
| PGEN | SELL · 10b5-1 | 2023-08-04 | 2023-08-04 | $1.10 | $116K | +36.5% | +47.7% | +0.0% |
| PGEN | BUY | 2023-01-27 | 2023-01-30 | $1.75 | $40K | +7.4% | -29.0% | -27.2% |
| PGEN | SELL | 2022-05-13 | 2022-05-16 | $1.19 | $424K | +3.9% | +1.6% | +104.7% |
| PGEN | SELL · 10b5-1 | 2022-01-05 | 2022-01-06 | $3.59 | $25K | -7.4% | -31.2% | -26.9% |
| PGEN | SELL · 10b5-1 | 2022-01-03 | 2022-01-04 | $3.67 | $14K | -10.0% | -38.4% | -29.5% |
| PGEN | SELL | 2021-07-19 | 2021-07-20 | $5.43 | $136K | -0.7% | -0.7% | -14.6% |
| PGEN | SELL | 2021-05-13 | 2021-05-14 | $6.40 | $607K | -2.9% | +2.0% | -11.4% |
| PGEN | SELL | 2021-01-06 | 2021-01-07 | $8.92 | $4.6M | -3.4% | -10.7% | -30.3% |
| PGEN | SELL | 2021-01-05 | 2021-01-06 | $10.56 | $191K | -15.4% | -15.4% | -26.6% |
| PGEN | SELL | 2021-01-04 | 2021-01-05 | $10.16 | $107K | -10.4% | -14.3% | -14.4% |
| PGEN | SELL | 2020-07-20 | 2020-07-21 | $4.58 | $112K | -10.6% | +18.3% | -3.8% |
| PGEN | SELL | 2020-05-15 | 2020-05-18 | $2.37 | $1.0M | -13.7% | +58.4% | +97.6% |
| PGEN | SELL · 10b5-1 | 2020-04-01 | 2020-04-02 | $3.01 | $16K | -3.2% | +22.6% | +69.0% |
| XON | SELL · 10b5-1 | 2020-01-06 | 2020-01-07 | $5.83 | $39K | -7.5% | N/A | N/A |
| XON | SELL · 10b5-1 | 2020-01-03 | 2020-01-06 | $5.77 | $22K | +2.1% | N/A | N/A |
| XON | SELL · 10b5-1 | 2020-01-02 | 2020-01-03 | $5.60 | $27K | +16.6% | N/A | N/A |
| XON | SELL · 10b5-1 | 2019-10-01 | 2019-10-02 | $5.50 | $28K | -0.2% | -13.3% | -7.4% |
| XON | SELL | 2019-07-18 | 2019-07-19 | $7.47 | $127K | +6.5% | -3.7% | -29.9% |
| XON | SELL · 10b5-1 | 2019-07-01 | 2019-07-02 | $7.76 | $37K | +1.2% | +2.8% | -22.7% |
| XON | SELL · 10b5-1 | 2019-01-03 | 2019-01-04 | $7.07 | $27K | +12.0% | +5.6% | -26.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.